| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 2653 |
| 1 | APIXABAN | 2352 |
| 2 | ABATACEPT | 1922 |
| 3 | RIVAROXABAN | 1536 |
| 4 | RISPERIDONE | 1509 |
| 5 | INFLIXIMAB | 1476 |
| 6 | ALENDRONATE SODIUM | 1455 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 1318 |
| 8 | METHOTREXATE SODIUM | 1274 |
| 9 | ESOMEPRAZOLE SODIUM | 1270 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 13 | 0.1204 |
| 1 | BEVACIZUMAB-AWWB | 25 | 0.0779 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 199 | 0.0753 |
| 3 | RUCAPARIB | 384 | 0.0619 |
| 4 | ALOSETRON HYDROCHLORIDE | 43 | 0.0569 |
| 5 | DASATINIB | 1013 | 0.0433 |
| 6 | LEVODOPA AND CARBIDOPA | 336 | 0.0411 |
| 7 | SELINEXOR | 76 | 0.0386 |
| 8 | TRASTUZUMAB-ANNS | 11 | 0.0381 |
| 9 | PEMBROLIZUMAB | 941 | 0.0359 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 4135 |
| 1 | Factor Xa Inhibitor [EPC] | 3880 |
| 2 | Atypical Antipsychotic [EPC] | 2834 |
| 3 | Corticosteroid [EPC] | 2651 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2475 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 1922 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1769 |
| 7 | Benzodiazepine [EPC] | 1722 |
| 8 | Anti-epileptic Agent [EPC] | 1578 |
| 9 | Progestin [EPC] | 1468 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 766 | 0.0323 |
| 1 | Folate Analog [EPC] | 1 | 0.0270 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 16 | 0.0267 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 1922 | 0.0252 |
| 4 | Partial Opioid Agonist/Antagonist [EPC] | 1 | 0.0233 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1769 | 0.0206 |
| 6 | Parathyroid Hormone-Related Peptide Analog [EPC] | 163 | 0.0206 |
| 7 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 24 | 0.0198 |
| 8 | Orexin Receptor Antagonist [EPC] | 189 | 0.0193 |
| 9 | Antidiarrheal [EPC] | 2 | 0.0192 |